Why is "Acute pain" trending?

Search Interest Perspective

• Placebo may be inferior compared to acetaminophen when given with morphine for the management of acute pain in the emergency department - 2 Minute Medicine
• Opioids aren't effective for many acute pain conditions, researchers warn - Medical Xpress
• 7 Reasons Managing Acute Pain Is Critical for Your Recovery - Everyday Health
• ASRA Session Highlights Noteworthy Innovations in Acute Pain Management - Anesthesiology News
• The burden of acute pain in the U.S. in the wake of the opioid crisis - Frontiers
• Vertex Pharmaceutical Stock Dives as Firm to Stop Developing Acute Pain Drug - MSN
• Undertreated Acute Pain Poses Long-Term Risks, But Prescription Opioids Still Do, Too ... - Patient Care Online
• Physician Views Results: Vertex's Journavx impresses in acute pain, as case for chronic comes into focus - FirstWord Pharma
• Study Challenges Long-Held Belief That Opioids Are Most Effective for Acute Pain - SciTechDaily
• Read "Framing Opioid Prescribing Guidelines for Acute Pain: Developing the Evidence" at NAP.edu - National Academies of Sciences, Engineering, and Medicine
• Why Does Acute Pain Get Better, But Chronic Pain Persist? - the-scientist.com
• Journavx for the Treatment of Moderate to Severe Acute Pain - Clinical Pain Advisor
• A study found that motion acupuncture (MSAT), a treatment that combines movement while acupuncture - 매일경제
• Why Acute Pain Can Be So Intense for Some and Not Others - Medscape
• Targeting sodium channels — challenges for acute pain and the leap to chronic pain - Nature
• Vertex’s Selective NaV1.8 Inhibitor Falls Short in Acute Pain Clinical Trial - appliedclinicaltrialsonline.com
• Ethical Dilemmas and Approaches to Acute Pain Management in Patients With Substance Use Disorders - Cureus
• Vertex drops aspiring Journavx follower in acute pain after phase 2 failure - Fierce Biotech
• 7 Best Medical and Therapeutic Interventions for Acute Pain - Everyday Health
• Managing Moderate-to-Severe Acute Pain in Adults - reference.medscape.com
• Acute Pain Management in Children: NSAIDs Offer Best Balance of Benefits and Harms - American Academy of Family Physicians | AAFP
• Chronic and Acute Pain Clinical Trial Pipeline Analysis: - GlobeNewswire
• FDA Approves Tapentadol for Relief of Moderate to Severe Acute Pain - Neurology Today
• Tris Pharma Announces Positive Debut Data from Phase 3 ALLEVIATE-1 and 2 Trials Evaluating Cebranopadol in Acute Pain at AAPM PainConnect 2026 Annual Meeting - Yahoo Finance
• Hispanic and Latino People with Acute Pain: 7 Tips to Overcome Barriers to Quality Care - Healthgrades
• Tris Pharma to Present Debut Data from Phase 3 ALLEVIATE - GlobeNewswire
• Black People and Acute Pain: How to Advocate for Care and Prevent Treatment Delays - Healthgrades
• Physician Views Preview: Checking in on Journavx's journey - FirstWord Pharma
• Vertex’s Journavx successor culled in acute pain after falling short in Phase II - Clinical Trials Arena
• NaV1.8 Pain Signal Inhibitor VX-993 Fails to Show Efficacy in Phase 2 Trial of Acute Pain - Neurology Live
• Opinion: New Painkillers Critical To Fight Opioid Epidemic, Broader Pain Crisis - BioSpace
• Evidence Supports Continuing Buprenorphine for Acute Pain in Those With Opioid Use Disorder - Physician's Weekly
• NOP agonist AT-403 promoted sleep in lactic acid-induced acute pain model - Frontiers
• Why a new opioid alternative is out of reach for some pain patients : Shots - Health News - npr.org
• SBI-810 relieves chronic and acute pain - BioWorld MedTech
• LNG emerges as acute pain point in West Asia war. ‘We’re on our way to doomsday gas crisis scenario’ - ThePrint
• Naturalistic acute pain states decoded from neural and facial dynamics - Nature
• Moderate-to-Severe Acute Pain Market Anticipates Impressive Growth Trajectory at a CAGR of 14% During the Study Period (2020-2034) | DelveInsight - Yahoo Finance
• Q&A: How Pediatricians Can Safely Prescribe Opioids for Acute Pain - Physician's Weekly
• Suzetrigine for Acute Pain Shows Promise Amid Data Gaps: ICER - Physician's Weekly
• Comparison of inhalational methoxyflurane, intranasal fentanyl, and intravenous morphine for treatment of prehospital acute pain in Norway (PreMeFen): a randomised, non-inferiority, three-arm, phase 3 trial - The Lancet
• Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain - PR Newswire
• In pain? You might have to suck it up - GroundUp
• Reviewing clinical approach to managing acute pain in horses - Vet Times
• FDA offers development roadmap for non-opioids to treat chronic pain - FirstWord Pharma
• Algia Pharma Gains FDA Support to Advance Novel Non-Opioid Pain Treatment Toward a Phase 2 Clinical Trial After IND-Enabling Studies With Indication Expanded to All Mild-to-Moderate Acute Pain - Business Wire
• 6 Pain Management Specialist Tips for People with Muscle Injuries - Healthgrades
• Opioid designed to stay inactive until swallowed hits Phase 3 milestone - Stock Titan
• Tris Pharma Announces Acceptance of New Review Article Highlighting Challenges of Treating Moderate-to-Severe Acute Pain with Currently Available Drugs - Business Wire
• Evidence Supports Buprenorphine for Acute Pain in Patients with Opioid Use Disorder - respiratory-therapy.com
• Decoding pain chronification: mechanisms of the acute-to-chronic transition - Frontiers
• Tris Pharma Announces Positive Debut Data from Phase 3 ALLEVIATE-1 and 2 Trials Evaluating Cebranopadol in Acute Pain at AAPM PainConnect 2026 Annual Meeting - The Manila Times
• Vertex Pharmaceutical Stock Dives as Firm to Stop Developing Acute Pain Drug - Investopedia
• FDA Approves Nonopioid Pain Medication in Novel Class for Treatment of Acute Pain - Drug Topics
• Vertex Pharmaceuticals Incorporated (VRTX) Launches JOURNAVX, First Non-Opioid Acute Pain Treatment - Yahoo Finance
• Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain - Business Wire
• Viatris’ Meloxicam Formulation Demonstrates Efficacy in Post-Surgical Acute Pain - Pharmaceutical Executive
• Journavx: Long awaited non-opioid treatment for acute pain hits the market - UCHealth
• Vertex announces the results of a Phase II study of VX-993 to treat acute pain - Manufacturing Chemist
• Vertex Partners with Basketball World Champion Jayson Tatum to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe-Acute Pain - Yahoo Finance
• Opioids not effective for acute pain - Pharmacy Daily
• Eina! Study shows hospitals are botching pain management - GroundUp
• Why acute and chronic pain are so different—and what might make pain last - Medical Xpress
• (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom
• First-in-Class Drug Approval for Acute Pain Highlights Need for Nonopioid Therapies - Drug Topics
• Expanding the toolkit for managing acute pain - peterattiamd.com
• Australia Acute Pain Market: Clinical Needs, Therapeutic Innovation & Healthcare Priorities - vocal.media
• Selective Inhibition of NaV1.8 with VX-548 for Acute Pain - The New England Journal of Medicine
• CUHK finds methadone far more effective than morphine for post-cardiac surgery pain relief: with 60% less acute pain and 70% lower opioid dependence - Chinese University of Hong Kong. Faculty of Medicine
• Evidence gap for acute pain outcomes in opioid use disorder - 2 Minute Medicine
• Managing Acute Pain in Patients on Medication-Assisted Treatment: A Practical Emergency Department Framework - Consultant360
• Viatris’ new form of old pain drug scores in large trials - BioPharma Dive
• As Journavx rollout begins, Vertex kicks off unbranded pain campaign with NFL alum Alex Smith - Fierce Pharma
• Journavx: Long awaited non-opioid treatment for acute pain hits the market - UCHealth
• How Do I Manage Acute Pain for Patients Prescribed Buprenorphine for Opioid Use Disorder? - NEJM Evidence
• Evidence supports continuing buprenorphine for acute pain in those with opioid use disorder - Medical Xpress
• Nonopioid drug for acute pain wins FDA approval - Science | AAAS
• Nonopioid drug candidate relieves acute pain in large trials - Science | AAAS
• Increased Use Of Medications For Opioid Use Disorder: Implications For Acute Pain Management - Health Affairs
• Beyond the Basics: How Should We Manage Acute Pain in Hospitalized Patients with OUD? - The Hospitalist
• Emergency departments likely overprescribing opioids for acute pain - 2 Minute Medicine
• AAFP, ACP Release New Acute Pain Clinical Guideline - American Academy of Family Physicians | AAFP
• A Shared Perspective on the Newly Approved Nonopioid Alternative for Acute Pain: Jessica Oswald, MD, MPH - Neurology Live
• Tris touts second Phase III success for dual NMR agonist in acute pain - FirstWord Pharma
• Functional connectivity response to acute pain assessed by fNIRS is associated with BDNF genotype in fibromyalgia: an exploratory study - Nature
• FDA Approves Vertex’s JOURNAVX as First Non-Opioid Acute Pain Reliever - Inside Precision Medicine
• FDA approves nonopioid Journavx for moderate to severe acute pain - Healio
• Novel Analgesic Suzetrigine May Offer Safe, Effective, Non-Opioid Control of Acute Pain - Medical Professionals Reference
• Burden of Acute Pain - Patient Care Online
• Proposing a short version of the Unesp-Botucatu pig acute pain scale using a novel application of machine learning technique - Nature
• Acute Pain Emergency - Clinical Advisor
• Acute Pain Management - The Hospitalist
• FDA approves new type of nonopioid painkiller for acute pain - NBC News
• Acute Pain Market Size to Reach USD 129.8 Million by 2035, Impelled by advancements in safe, effective treatment options - BioSpace
• The association between age and acute pain sensitivity in patients with Herpes Zoster - Nature
• Peripheral Nerve Stimulation for Treating Acute Pain Following Traumatic Fracture: A Case Report of Rapid-Onset Analgesia Without Motor Blockade - Cureus
• Management of Acute Pain from Musculoskeletal Injuries: Guidance for Family Physicians - American Academy of Family Physicians | AAFP
• What is the analgesic range of acupuncture stimulus for treating acute pain? - Frontiers
• Integrating Artificial Intelligence in Perioperative Pain Management: Towards an Innovative Acute Pain Service - Cureus
• Latigo Biotherapeutics Granted FDA Fast Track Designation for LTG-001, Potential Best-in-Class Nav1.8 Inhibitor for the Non-Opioid Treatment of Acute Pain - PR Newswire